However, the capacity of A2AR activation to also protect against IRI in fatty liver has not been yet ascertained, and the effects of A2AR signaling on the pathogenic mechanisms that are involved in the increased susceptibility of fatty liver to IRI are still unknown. The gene discussed is ADORA2A; the disease is fatty liver disease.